1 / 5

Glasgow Coma Scale scores, early opioids, and 4-year psychological outcomes among combat amputees

Glasgow Coma Scale scores, early opioids, and 4-year psychological outcomes among combat amputees. Ted Melcer, PhD; Jay Walker, BA; Vibha Bhatnagar, MD; Erin Richard, MPH; Peggy Han, MPH; V. Franklin Sechriest II, MD; Martin Lebedda, RN; Kimberly Quinn, RN; Michael Galarneau, MS, NREMT. Aim

jun
Télécharger la présentation

Glasgow Coma Scale scores, early opioids, and 4-year psychological outcomes among combat amputees

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Glasgow Coma Scale scores, early opioids, and 4-year psychologicaloutcomes among combat amputees Ted Melcer, PhD; Jay Walker, BA; Vibha Bhatnagar, MD; Erin Richard, MPH; Peggy Han, MPH; V. Franklin Sechriest II, MD; Martin Lebedda, RN; Kimberly Quinn, RN; Michael Galarneau, MS, NREMT

  2. Aim • Use military and VA health data to investigate effect of early postinjury medications on 4 yr psychological outcomes of combat amputees. • Relevance • Morphine and fentanyl are frequently used for analgesia after trauma, but their advantages and disadvantages are debated.

  3. Method • Retrospective review of existing medical records of U.S. combat amputees injured 2001-2008 in Iraq or Afghanistan. • In-theater combat casualty records (n = 145) documented Glasgow Coma Scale (GCS) scores and/or morphine, fentanyl, or no opioid treatment within hours of injury.

  4. Results • GCS scores were not significantly associated with posttraumatic stress disorder (PTSD). • Longitudinal modeling using 4 (yearly) time points showed significantly reduced likelihood of PTSD for patients treated with morphine (vs fentanyl). • Reduced PTSD prevalence for morphine was significant, specifically among patients with traumatic brain injury during first 2 yr postinjury. • PTSD prevalence, but not other disorders, increased between year 1 and years 2-4 postinjury.

  5. Conclusion • Primary clinical implication: • Combat care physicians may consider PTSD prevention as potential benefit of choosing early morphine (with or without fentanyl) vs fentanyl alone • Second implication: • Military and VA providers should screen for mental health disorders, particularly PTSD, during routine healthcare visits (e.g., primary care) for several years after injury.

More Related